Emtricitabine and Tenofovir Alafenamide
DESCOVY
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
NADAC/unit
$71.4125
No Shortage
Tier 1: 35.9%
1 Manufacturers
1 ANDAs
Emtricitabine and Tenofovir Alafenamide blocks HIV replication by inhibiting reverse transcriptase.
vs. brand DESCOVY: Generic saves up to -614% per unit
Generic Manufacturers
GILEAD SCIENCES INCLUPIN LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.